[Federal Register Volume 85, Number 55 (Friday, March 20, 2020)]
[Notices]
[Pages 16104-16105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05921]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Council on Blood Stem Cell
Transplantation
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Secretary's Advisory Council on Blood Stem
Cell Transplantation (ACBSCT) has scheduled a public meeting.
Information about ACBSCT and the agenda for this meeting can be found
on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council
DATES: April 27, 2020, 8:00 a.m.-4:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held by webinar and conference call.
The webinar link, conference call-in number, registration information,
and meeting materials can be accessed
[[Page 16105]]
through the registration link on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.
FOR FURTHER INFORMATION CONTACT: Robert Walsh, Designated Federal
Official, (DFO), at Division of Transplantation, HRSA, 5600 Fishers
Lane, 8W60, Rockville, Maryland 20857; 301-443-6839; or
[email protected].
SUPPLEMENTARY INFORMATION: ACBSCT provides advice and recommendations
to the Secretary of HHS (Secretary) and the HRSA Administrator on the
activities of the C.W. Bill Young Cell Transplantation Program
(CWBYCTP) and the National Cord Blood Inventory (NCBI) Program. The
principal purpose of these programs is to make blood stem cells from
adult donors and cord blood units available for patients who need a
transplant to treat life-threatening conditions such as leukemia, and
who lack a suitably matched relative who can be the donor.
During the April 27, 2020, meeting, the ACBSCT will discuss issues
related to increasing access to transplantation (including the
utilization of cord blood and other types of cellular therapy). Agenda
items are subject to change as priorities dictate. Refer to the ACBSCT
website for any updated information concerning the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to ACBSCT should be
sent to Robert Walsh, DFO, using the contact information above at least
3 business days prior to the meeting.
Individuals planning to participate who need special assistance or
another reasonable accommodation should notify Robert Walsh at the
address and phone number listed above at least 10 business days prior
to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-05921 Filed 3-19-20; 8:45 am]
BILLING CODE 4165-15-P